StockData
ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc. (ADRX) income statement

ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$14.16+1.34 (+10.45%)

Close on Nov 19, 2026Market cap $1.52BP/E –Yield –

ADARx Pharmaceuticals, Inc. income statement

AnnualQuarterlyTTM

This company has not reported income statement data in its XBRL filings.

Ratios

Latest available

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY
–

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
2.64
Dividend yield
–

See a number that looks wrong?